[ORGANIZATION]
Pembrolizumab
Featured in 6 tracked stories · first seen
Situations
Moderna and Merck melanoma vaccine clinical trials
16 clusters · 450 sources · last updated
Latest: Moderna expands cancer therapy ties and benefits from vaccine program news
Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (V940), an experimental personalized mRNA cancer vaccine. The INTerpath-001 trial, which administered the vaccine alon
Also covered in
-
Pembrolizumab immunotherapy usage and stock in Kosovo
[HEALTH] · 2 sources ·
-
FDA approves sacituzumab govitecan as first‑line therapy for metastatic triple‑negative breast cancer
[HEALTH] · 2 sources ·